The Bone Microarchitecture Deficit in Patients with Hemophilia Is Influenced by Arthropathy, Hepatitis C Infection, and Physical Activity.

Published on Sep 29, 2021in Thrombosis and Haemostasis5.723
· DOI :10.1055/S-0041-1735964
Katharina Holstein12
Estimated H-index: 12
(UHH: University of Hamburg),
Leonora Witt2
Estimated H-index: 2
(UHH: University of Hamburg)
+ 5 AuthorsFlorian Langer8
Estimated H-index: 8
(UHH: University of Hamburg)
Sources
Abstract
Low bone mineral density (BMD) is common in patients with hemophilia (PWHs). The aim of the present study was to describe BMD and microarchitecture in PWHs in Northern Germany and to determine factors contributing to possible skeletal alterations. Demographic characteristics, BMD and microarchitecture, bone metabolism markers, and orthopaedic joint score (OJS) were assessed during routine check-ups. Areal BMD was assessed by dual-energy X-ray absorptiometry (DXA) at the hip and lumbar spine. Volumetric BMD and microarchitecture were quantified by high-resolution peripheral quantitative computed tomography at the distal radius and tibia. Eighty male PWHs (median age, 33 years; range, 18–77) were retrospectively analyzed, of whom 67 (84.0%) and 13 (16.0%) had hemophilia A and B, respectively. Fifty-four (68.0%), six (7.0%), and 20 (25.0%) patients had severe, moderate, or mild hemophilia, and 35 (44.0%) were hepatitis C virus (HCV) positive. DXA analysis revealed low BMD (Z-score ≤ − 2.0) in 27.5% of PWHs, and higher bone turnover values were associated with lower BMD. Bone microarchitecture was dominated by cortical deficits at the radius and trabecular deficits at the tibia. Cortical deficits at the radius were influenced by lower body mass index, low-grade inflammation, and treatment regimen (higher cortical thickness on primary prophylaxis). Trabecular alterations at the tibia were mainly associated with OJS and HCV status. A positive effect of self-reported sportive activity on BMD could be shown. In conclusion, our findings demonstrate that the site-specific microarchitectural deficit observed in PWHs is primarily negatively influenced by poor joint status, inflammation, HCV infection, and high bone turnover.
📖 Papers frequently viewed together
2021
7 Authors (Xiaoyin Peng, ..., Fang Song)
References41
Newest
#1Tim Rolvien (UHH: University of Hamburg)H-Index: 16
#2Michael Amling (UHH: University of Hamburg)H-Index: 75
Disuse osteoporosis describes a state of bone loss due to local skeletal unloading or systemic immobilization. This review will discuss advances in the field that have shed light on clinical observations, mechanistic insights and options for the treatment of disuse osteoporosis. Clinical settings of disuse osteoporosis include spinal cord injury, other neurological and neuromuscular disorders, immobilization after fractures and bed rest (real or modeled). Furthermore, spaceflight-induced bone lo...
Source
#1Silvia LinariH-Index: 18
#2Daniela MelchiorreH-Index: 16
Last. Giancarlo CastamanH-Index: 67
view all 7 authors...
INTRODUCTION Haemophilia (H) is frequently associated with a multifactorial reduction in bone mineral density (BDM), but little is known about possible differences between HA and HB according to their severity. AIM To evaluate the association between low bone mineral density (BMD), 25-hydroxyvitamin D [25(OH)D] concentrations and bone turnover markers in patients with HA and HB younger or older than 50 years. METHODS In 78 patients 50 years with severe (S) or moderate (M) HA and HB, BMD was meas...
Source
#1Nevine G. Andrawes (Ain Shams University)H-Index: 7
#2Manal Hashem Fayek (Ain Shams University)H-Index: 4
Last. Raguia Atef MostafaH-Index: 1
view all 4 authors...
BACKGROUND: Decreased bone mineral density (BMD) is a significant morbidity in haemophilia. Vitamin D is important for the bone health of people with haemophilia. Regular factor VIII prophylaxis can prevent bleeding and arthropathy. AIM: To determine the 25(OH) vitamin D level in severe haemophilia A patients and correlate it to their Hemophilia Joint Health Score (HJHS) and dual-energy X-ray absorptiometry (DEXA). We also compared the 25(OH) vitamin D and DEXA in haemophilia A and healthy child...
Source
#1Sarah Taves (UNC: University of North Carolina at Chapel Hill)H-Index: 9
#2Junjiang Sun (UNC: University of North Carolina at Chapel Hill)H-Index: 14
Last. Paul E. Monahan (UNC: University of North Carolina at Chapel Hill)H-Index: 34
view all 10 authors...
While joint damage is the primary co-morbidity of hemophilia, osteoporosis and osteopenia are also observed. Coagulation factor VIII deficient (FVIII−/−) mice develop an osteoporotic phenotype in the absence of induced hemarthrosis that is exacerbated two weeks after an induced joint injury. Here we have compared comprehensively the bone health of clotting factor VIII, factor IX, and Von Willebrand Factor knockout (FVIII−/−, FIX−/−, and VWF−/− respectively) mice both in the absence of joint hemo...
Source
#1Omer Ekinci (Fırat University)H-Index: 4
#2Sinan Demircioğlu (Yüzüncü Yıl University)H-Index: 5
Last. Cengiz Demir (Yüzüncü Yıl University)H-Index: 12
view all 6 authors...
INTRODUCTION: Haemophilia patients may exhibit lower levels of bone mineral density (BMD) than the general population for a variety of reasons. AIM: We aimed to investigate decreased BMD in people with severe adult haemophilia A (PWH) living in eastern Turkey, and to evaluate the related potential risk factors. METHODS: The study included 41 PWH and 40 healthy volunteers. Dual-energy x-ray absorptiometry (DXA) was used to measure the BMD. Blood tests and body mass index (BMI) were recorded. The ...
Source
Objectives:The objectives of this study were to study bone mineral content (BMC), bone mineral density (BMD), vitamin D level, and bone turnover markers in children with hemophilia and compare it with their normal counterparts.Design:This was an observational case-control study.Setting:This study wa
Source
#1Serdar Sahin (Istanbul University)H-Index: 3
#2Sevil SadriH-Index: 5
Last. Muhlis Cem Ar (Istanbul University)H-Index: 11
view all 4 authors...
Increased number of patients with hemophilia have been identified to have osteoporosis at early ages. Low bone mineral density in the setting of hemophilia has been associated with decreased mobili...
Source
#1Tobias Schmidt (UHH: University of Hamburg)H-Index: 11
#2Dorothee Schwinge (UHH: University of Hamburg)H-Index: 15
Last. Michael Amling (UHH: University of Hamburg)H-Index: 75
view all 19 authors...
Background & Aims Osteoporotic fractures are a major cause of morbidity and reduced quality of life in patients with primary sclerosing cholangitis (PSC), a progressive bile duct disease of unknown origin. Although it is generally assumed that this pathology is a consequence of impaired calcium homeostasis and malabsorption, the cellular and molecular causes of PSC-associated osteoporosis are unknown. Methods We determined bone mineral density by dual-X-ray absorptiometry and assessed bone micro...
Source
In this study, we aimed to investigate changes in calcium (Ca) metabolism in hemophilia patients (PWH). We also aimed to investigate the importance of diagnosis and treatment of factors impairing calcium metabolism and the significance of early diagnosis and prophylaxis with respect to these subject
Source
#1Fabio Massimo Ulivieri (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)H-Index: 19
#2G. A. A Rebagliati (University of Milan)H-Index: 3
Last. Elena Santagostino (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)H-Index: 66
view all 9 authors...
INTRODUCTION: Haemophilia is a recessive X-linked inherited bleeding disorder, whose typical symptom is spontaneous intra-articular haemorrhage leading to joint damage, which can be quantified by the Haemophilia Joint Health Score (HJHS). Arthropathy and other characteristics of haemophilic patients may reduce bone mineral density (BMD), increasing the risk for fragility fractures, which also may occur due to bone quality impairment. AIM: To evaluate bone quantity by BMD and bone quality by Trab...
Source
Cited By0
Newest
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.